| Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma K Kropivsek, P Kachel, S Goetze, R Wegmann, Y Festl, Y Severin, ... Nature Cancer 4 (5), 734-753, 2023 | 28 | 2023 |
| A novel dual-cytokine–antibody fusion protein for the treatment of CD38-positive malignancies R De Luca, P Kachel, K Kropivsek, B Snijder, MG Manz, D Neri Protein Engineering, Design and Selection 31 (5), 173-179, 2018 | 11 | 2018 |
| Postnatal Dynamics of Zeb2 Expression in Rat Brain: Analysis of Novel 3′ UTR Sequence Reveals a miR-9 Interacting Site K Kropivšek, J Pickford, DA Carter Journal of Molecular Neuroscience 52, 138-147, 2014 | 5 | 2014 |
| Research briefing B Snijder, K Kropivsek Nature 4, 594-595, 2023 | | 2023 |
| A roadmap of therapeutic strategies for patients with multiple myeloma B Snijder, K Kropivsek Nature Cancer, 2023 | | 2023 |
| P856: A SINGLE-CELL FUNCTIONAL PRECISION MEDICINE LANDSCAPE OF MULTIPLE MYELOMA K Kropivsek, P Kachel, S Goetze, R Wegmann, Y Severin, BD Hale, ... HemaSphere 6, 749-750, 2022 | | 2022 |
| A single-cell functional precision medicine landscape of multiple myeloma K Kropivsek ETH Zurich, 2022 | | 2022 |
| Development of Thin Plasma Polymer Films for Culturing Corneal Endothelial Cells: Diploma Thesis K Kropivšek University of Ljubljana, Faculty of Chemistry and Chemical Biology, 2013 | | 2013 |
Berend SnijderSNF Professor at the Institute of Molecular Systems Biology, ETHZ在 ethz.ch 的电子邮件经过验证
